S&P 500
7,539.20
-0.14%
Dow Jones
52,501.20
-0.02%
Nasdaq 100
29,693.60
-0.19%
Russell 2000
2,986.31
-0.15%
FTSE 100
10,482.30
+0.02%
Nikkei 225
68,917.20
-0.16%

Investing

ACET logo Adicet Bio : ACET

ACET

Stock Data

$8.94

Change down

$0.31 (3.35%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Adicet Bio Inc is a pioneering biotechnology firm based in Boston, Massachusetts, focused on developing innovative cancer treatments. It specializes in creating allogeneic gamma delta T cell therapies, a cutting-edge approach that aims to improve the body's immune response against tumors. The company's flagship product, ADI-001, is currently undergoing clinical trials for non-Hodgkin’s lymphoma. Additionally, Adicet Bio is working on other promising therapies, including ADI-002 for solid tumors and ADI-925, which targets tumor stress ligands for enhanced cancer targeting.

All Adicet Bio Articles

1 Article